DorsaVi (ASX: DVL) has announced two significant commercial milestones, the Dr Patel collaboration and the SEROMA European study, totalling over A$200,000 in contracted revenue. T ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results